Free Trial
NASDAQ:QTTB

Q32 Bio (QTTB) Stock Price, News & Analysis

Q32 Bio logo
$1.75 +0.04 (+2.34%)
As of 10:28 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Q32 Bio Stock (NASDAQ:QTTB)

Key Stats

Today's Range
$1.66
$1.75
50-Day Range
$1.36
$3.32
52-Week Range
$1.35
$53.79
Volume
3,633 shs
Average Volume
615,001 shs
Market Capitalization
$21.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.17
Consensus Rating
Hold

Company Overview

Q32 Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

QTTB MarketRank™: 

Q32 Bio scored higher than 55% of companies evaluated by MarketBeat, and ranked 521st out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Q32 Bio has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 2 buy ratings, 6 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Q32 Bio has received no research coverage in the past 90 days.

  • Read more about Q32 Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Q32 Bio are expected to grow in the coming year, from ($12.32) to ($3.84) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Q32 Bio is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Q32 Bio is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Q32 Bio's valuation and earnings.
  • Percentage of Shares Shorted

    8.02% of the float of Q32 Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Q32 Bio has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Q32 Bio has recently decreased by 13.66%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Q32 Bio does not currently pay a dividend.

  • Dividend Growth

    Q32 Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.02% of the float of Q32 Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Q32 Bio has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Q32 Bio has recently decreased by 13.66%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Q32 Bio has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Q32 Bio this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Q32 Bio insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $31,903.00 in company stock.

  • Percentage Held by Insiders

    40.00% of the stock of Q32 Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 31.32% of the stock of Q32 Bio is held by institutions.

  • Read more about Q32 Bio's insider trading history.
Receive QTTB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Q32 Bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

QTTB Stock News Headlines

Buffett, Gates and Bezos Dumping Stocks
The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t see in America for more than a century.tc pixel
Q32 Bio (QTTB) Q2 Loss Drops 45%
See More Headlines

QTTB Stock Analysis - Frequently Asked Questions

Q32 Bio's stock was trading at $3.44 at the beginning of the year. Since then, QTTB shares have decreased by 50.3% and is now trading at $1.71.

Q32 Bio Inc. (NASDAQ:QTTB) released its quarterly earnings results on Wednesday, August, 6th. The company reported ($0.78) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.14) by $0.36.

Q32 Bio's top institutional shareholders include Monaco Asset Management SAM (4.85%), Geode Capital Management LLC (0.50%), Jane Street Group LLC (0.38%) and Marshall Wace LLP (0.14%). Insiders that own company stock include Jodie Pope Morrison, Shelia M Violette and Paul Alloway.
View institutional ownership trends
.

Shares of QTTB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Q32 Bio investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Meta Platforms (META), Netflix (NFLX) and Alphabet (GOOG).

Company Calendar

Last Earnings
8/06/2025
Today
9/03/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:QTTB
Previous Symbol
NASDAQ:QTTB
CIK
1661998
Fax
N/A
Employees
39
Year Founded
N/A

Price Target and Rating

High Price Target
$22.00
Low Price Target
$3.00
Potential Upside/Downside
+611.5%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.30)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.73 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-2,709.70%
Return on Assets
-61.16%

Debt

Debt-to-Equity Ratio
1.68
Current Ratio
5.06
Quick Ratio
5.06

Sales & Book Value

Annual Sales
$1.16 million
Price / Sales
17.98
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.00) per share
Price / Book
-1.71

Miscellaneous

Outstanding Shares
12,200,000
Free Float
7,319,000
Market Cap
$20.86 million
Optionable
N/A
Beta
0.07
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:QTTB) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners